Anti-Mullerian Hormone Test

One of the key indicators of a woman's fertility is her Anti-Müllerian Hormone (AMH) levels, which provide valuable insight into her ovarian reserve and overall reproductive function.

This article will explore the role of AMH in fertility, and offer a comprehensive guide to understanding how it impacts fertility assessment, treatment, and family planning decisions.

What is Anti-Müllerian Hormone (AMH)?

Anti-Müllerian Hormone (AMH) is a protein produced by the cells of developing ovarian follicles, playing a crucial role in ensuring that only a select few ovarian follicles reach maturity and are released during ovulation. 

As women age, AMH levels naturally decline, reflecting the gradual depletion of ovarian reserve. Unlike other reproductive hormones, AMH levels remain relatively stable throughout menstrual cycles, making it a reliable marker for assessing ovarian function.

What will an AMH test tell me?

The AMH test is a valuable tool in assessing a woman's reproductive potential. Here's what it can tell you:

1. Ovarian reserve

   • AMH levels provide an estimate of the number of eggs remaining in a woman's ovaries. This is known as the ovarian reserve.

2. Fertility potential

   • Higher AMH levels generally suggest a greater number of eggs and potentially better fertility prospects. Lower levels may indicate a diminished ovarian reserve.

3. Response to fertility treatments

   • AMH levels can help predict how well a woman might respond to assisted reproductive technologies such as in vitro fertilisation (IVF).

4. Reproductive lifespan

   • The test can offer insights into a woman's reproductive lifespan, though it cannot predict the exact age of menopause.

5. PCOS indication

   • Unusually high AMH levels may suggest polycystic ovary syndrome (PCOS), a common cause of infertility.

It's important to note that while the AMH test is informative, it does not provide a complete picture of fertility. Other factors, such as egg quality, which AMH does not measure, also play crucial roles in conception.

For a comprehensive fertility assessment, consult a fertility specialist who can interpret your AMH results alongside other relevant tests and your medical history.

What factors influence AMH levels?

1. Age

   • AMH levels naturally decline with age, reflecting the decrease in ovarian reserve as women approach menopause.

2. Genetics

   • Some women naturally have higher or lower levels of AMH than others.

3. Lifestyle factors

   • Smoking has been shown to reduce AMH levels, while a healthy diet and regular exercise may help maintain ovarian health.

4. Medical conditions

   • Women with polycystic ovary syndrome (PCOS) often have higher AMH levels due to the presence of multiple small ovarian follicles.

   • Conversely, women with conditions like premature ovarian insufficiency (POI) may have lower AMH levels, reflecting a reduced ovarian reserve.

How is the AMH test performed?

AMH testing is a simple blood test that can be performed at any point in a woman’s menstrual cycle, providing insight into a woman’s ovarian reserve. 

How to interpret AMH levels?

Typical AMH level ranges:

• High: Above 3.0 ng/mL (suggestive of PCOS)
• Normal: 1.0 - 3.0 ng/mL
• Low: Below 1.0 ng/mL (indicative of low ovarian reserve)

Higher AMH levels generally indicate a greater number of eggs, while lower levels suggest a diminished reserve. Interpreting AMH results requires the expertise of a fertility specialist, as the levels must be considered in the context of a woman’s age, overall health, and reproductive goals.

While AMH is a valuable tool in assessing fertility, it is not the sole determinant of a woman’s reproductive potential. Other factors, such as egg quality, sperm health, and uterine conditions, also play a significant role in fertility outcomes.
Enquire more here.

What are the limitations of AMH tests?

• While AMH is a valuable tool in assessing ovarian reserve, it is not an absolute predictor of fertility potential. AMH levels do not directly measure egg quality, a crucial factor in fertility. A woman may have a high AMH level but still experience challenges in conceiving if her egg quality is compromised. 
• In addition, AMH testing cannot predict the exact timing of menopause or the likelihood of natural conception. Besides, AMH levels can vary slightly between testing methods and laboratories, leading to potential discrepancies in results.

When to seek medical advice?

While AMH testing can provide valuable insights, it is important to recognise when further evaluation or intervention is needed. Consider seeking medical advice if you experience: 

1. Low AMH levels

   • If testing reveals low AMH levels, especially in women under 35, this may indicate a reduced ovarian reserve. 

2. Difficulty conceiving

   • Couples who have been trying to conceive for a year without success (or six months for women over 35) should consider AMH testing as part of a broader fertility evaluation. 

3. Family planning concerns

   • Women planning to delay pregnancy for personal or professional reasons might benefit from understanding their AMH levels and their reproductive timeline.

4. Family history of early menopause

   • Women with a family history of early menopause might seek AMH testing to gauge their ovarian reserve and fertility window.

5. Considering fertility treatments

   • Before embarking on fertility treatments like IVF, consulting a specialist to interpret AMH levels can help in tailoring treatment plans for the best outcomes.

AMH serves as a crucial indicator of ovarian reserve and can guide fertility treatment options, helping women make informed decisions. For those facing challenges with fertility, planning to delay pregnancy, or having concerns about reproductive health, consulting a fertility specialist is essential.

The information provided is intended for general guidance only and should not be considered medical advice. For personalised recommendations and tailored advice, please consult a fertility specialist at Thomson Medical. Book an appointment with Thomson Fertility Centre today.